Literature DB >> 32014551

Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.

Helen E Collins1, John C Chatham2.   

Abstract

The post-translational modification of serine and threonine residues of nuclear, cytosolic, and mitochondrial proteins by O-linked β-N-acetyl glucosamine (O-GlcNAc) has long been seen as an important regulatory mechanism in the cardiovascular system. O-GlcNAcylation of cardiac proteins has been shown to contribute to the regulation of transcription, metabolism, mitochondrial function, protein quality control and turnover, autophagy, and calcium handling. In the heart, acute increases in O-GlcNAc have been associated with cardioprotection, such as those observed during ischemia/reperfusion. Conversely, chronic increases in O-GlcNAc, often associated with diabetes and nutrient excess, have been shown to contribute to cardiac dysfunction. Traditionally, many studies have linked changes in O-GlcNAc with nutrient availability and as such O-GlcNAcylation is often seen as a nutrient driven process. However, emerging evidence suggests that O-GlcNAcylation may also be regulated by non-nutrient dependent mechanisms, such as transcriptional and post-translational regulation. Therefore, the goals of this review are to provide an overview of the impact of O-GlcNAcylation in the cardiovascular system, how this is regulated and to discuss the emergence of regulatory mechanisms other than nutrient availability.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiomyocyte; GFAT; Heart; Metabolism; Nutrient regulation; O-GlcNAc; O-GlcNAc transferase (OGT); O-GlcNAcase (OGA)

Mesh:

Substances:

Year:  2020        PMID: 32014551      PMCID: PMC7703857          DOI: 10.1016/j.bbadis.2020.165712

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  113 in total

1.  O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy.

Authors:  Heberty T Facundo; Robert E Brainard; Lewis J Watson; Gladys A Ngoh; Tariq Hamid; Sumanth D Prabhu; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-09       Impact factor: 4.733

2.  In vivo and in vitro evidence that chronic activation of the hexosamine biosynthetic pathway interferes with leptin-dependent STAT3 phosphorylation.

Authors:  Arthur D Zimmerman; Ruth B S Harris
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-01-07       Impact factor: 3.619

3.  Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.

Authors:  Susan A Marsh; Louis J Dell'Italia; John C Chatham
Journal:  Amino Acids       Date:  2010-07-30       Impact factor: 3.520

4.  Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria.

Authors:  Partha S Banerjee; Junfeng Ma; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

5.  Glucose deprivation-induced increase in protein O-GlcNAcylation in cardiomyocytes is calcium-dependent.

Authors:  Luyun Zou; Xiaoyuan Zhu-Mauldin; Richard B Marchase; Andrew J Paterson; Jian Liu; Qinglin Yang; John C Chatham
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

6.  Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation.

Authors:  Raymond J Clark; Patrick M McDonough; Eric Swanson; Susanne U Trost; Misa Suzuki; Minoru Fukuda; Wolfgang H Dillmann
Journal:  J Biol Chem       Date:  2003-08-26       Impact factor: 5.157

7.  Identification of a novel serine phosphorylation site in human glutamine:fructose-6-phosphate amidotransferase isoform 1.

Authors:  Yanyan Li; Céline Roux; Sylvie Lazereg; Jean-Pierre LeCaer; Olivier Laprévote; Bernard Badet; Marie-Ange Badet-Denisot
Journal:  Biochemistry       Date:  2007-10-17       Impact factor: 3.162

8.  Removal of Abnormal Myofilament O-GlcNAcylation Restores Ca2+ Sensitivity in Diabetic Cardiac Muscle.

Authors:  Genaro A Ramirez-Correa; Junfeng Ma; Chad Slawson; Quira Zeidan; Nahyr S Lugo-Fagundo; Mingguo Xu; Xiaoxu Shen; Wei Dong Gao; Viviane Caceres; Khalid Chakir; Lauren DeVine; Robert N Cole; Luigi Marchionni; Nazareno Paolocci; Gerald W Hart; Anne M Murphy
Journal:  Diabetes       Date:  2015-06-24       Impact factor: 9.461

9.  O-GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O-GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload.

Authors:  Wei-Zhong Zhu; Danny El-Nachef; Xiulan Yang; Dolena Ledee; Aaron K Olson
Journal:  J Am Heart Assoc       Date:  2019-06-04       Impact factor: 5.501

10.  The Role of PTP1B O-GlcNAcylation in Hepatic Insulin Resistance.

Authors:  Yun Zhao; Zhuqi Tang; Aiguo Shen; Tao Tao; Chunhua Wan; Xiaohui Zhu; Jieru Huang; Wanlu Zhang; Nana Xia; Suxin Wang; Shiwei Cui; Dongmei Zhang
Journal:  Int J Mol Sci       Date:  2015-09-22       Impact factor: 5.923

View more
  2 in total

1.  Increasing O-GlcNAcylation is neuroprotective in young and aged brains after ischemic stroke.

Authors:  Zhuoran Wang; Xuan Li; Ivan Spasojevic; Liping Lu; Yuntian Shen; Xingguang Qu; Ulrike Hoffmann; David S Warner; Wulf Paschen; Huaxin Sheng; Wei Yang
Journal:  Exp Neurol       Date:  2021-02-15       Impact factor: 5.330

Review 2.  Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes.

Authors:  Jessica C Garbern; Richard T Lee
Journal:  Stem Cell Res Ther       Date:  2021-03-12       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.